Infinity Pharmaceuticals | INFI - Spese Di Vendita E Di Amministrazione





Spese Di Vendita E Di Amministrazione Cambiamento Data
AbbVie USD 3.58B 316M 2026-03
Alterity Therapeutics Limited AUD 1.45M 703.96K 2025-12
Amgen USD 1.58B 354M 2026-03
AstraZeneca USD 5.06B 455M 2026-03
Bristol-Myers Squibb USD 1.62B 564M 2026-03
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.21M 120K 2025-12
CSL USD 1.23B 498M 2025-12
Eisai JPY 111.72B 7.86B 2025-12
Eli Lilly USD 2.93B 198M 2026-03
Gilead Sciences USD 1.45B 326M 2026-03
GlaxoSmithKline GBP 2.12B 558M 2026-03
Grifols EUR 320.45M 12.65M 2025-12
Incyte USD 328.1M 62.31M 2026-03
Infinity Pharmaceuticals USD 3.75M 2.19M 2023-06
Ionis Pharmaceuticals USD 151M 21M 2026-03
J&J USD 6.03B 719M 2026-03
Novartis USD 3.14B 296M 2026-03
Pfizer USD 2.92B 1.16B 2026-03
Plus Therapeutics USD 3.49M 559K 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
TG Therapeutics USD 73.14M 22.42M 2026-03